SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-18-000552
Filing Date
2018-03-21
Accepted
2018-03-21 17:01:13
Documents
1
Period of Report
2018-02-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2989
  Complete submission text file 0001123292-18-000552.txt   4328
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address
Keefer Jason (Reporting) CIK: 0001717590 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32966 | Film No.: 18705039